Mitochondrial dynamics in cisplatin resistance: molecular mechanisms and therapeutic targeting. [PDF]
Huang W, Sun W, Yang Z, Li Y, Wang Z.
europepmc +1 more source
Inflammasome activation contributes to cisplatin resistance in ovarian cancer. [PDF]
de Souza JC +6 more
europepmc +1 more source
HMGB1 Assists in Overcoming Cisplatin Resistance in Chemoresistant Human Ovarian Cancer Cells. [PDF]
Huynh V +3 more
europepmc +1 more source
Targeting the METTL3/PCNA axis with STM2457 overcomes cisplatin resistance in osteosarcoma. [PDF]
Yu H, Li S, Liu J.
europepmc +1 more source
Mitochondrial HMGCS1 mediates cisplatin resistance in cervical cancer through regulation of mitochondrial transcription. [PDF]
Yang W +6 more
europepmc +1 more source
VAMP7 governs ferroptosis suppression and cisplatin resistance in esophageal cancer: a dual-targeting therapeutic paradigm. [PDF]
Zhu J +6 more
europepmc +1 more source
Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer. [PDF]
Xu JY +8 more
europepmc +1 more source
Dual-activated fluorescent probe for the study of the mechanism of SO<sub>2</sub> and NO in cisplatin resistance of nasopharyngeal carcinoma. [PDF]
Wang X, Li X, Chen X, Wang D.
europepmc +1 more source
Targeting shared mechanisms of cisplatin resistance and metastasis in lung cancer for novel therapeutic strategies. [PDF]
Liang X, Zhu X, Zhang Y, Chen M, Liu N.
europepmc +1 more source
Molecular Signature of Cisplatin Resistance in Ovarian Cancer Identifies Therapeutic Opportunities for Re-sensitization. [PDF]
Mansour M +4 more
europepmc +1 more source

